nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—DRD1—autistic disorder	0.467	0.647	CbGaD
Zuclopenthixol—HTR2A—autistic disorder	0.254	0.353	CbGaD
Zuclopenthixol—DRD1—telencephalic ventricle—autistic disorder	0.00812	0.0799	CbGeAlD
Zuclopenthixol—HTR2A—cerebellar cortex—autistic disorder	0.00544	0.0535	CbGeAlD
Zuclopenthixol—DRD2—telencephalic ventricle—autistic disorder	0.0048	0.0472	CbGeAlD
Zuclopenthixol—HTR2A—pons—autistic disorder	0.00384	0.0378	CbGeAlD
Zuclopenthixol—HTR2A—telencephalic ventricle—autistic disorder	0.00316	0.0311	CbGeAlD
Zuclopenthixol—HTR6—forebrain—autistic disorder	0.00285	0.028	CbGeAlD
Zuclopenthixol—DRD5—forebrain—autistic disorder	0.00277	0.0273	CbGeAlD
Zuclopenthixol—HTR6—telencephalon—autistic disorder	0.00262	0.0258	CbGeAlD
Zuclopenthixol—DRD5—telencephalon—autistic disorder	0.00255	0.0251	CbGeAlD
Zuclopenthixol—ADRA1A—hindbrain—autistic disorder	0.00231	0.0227	CbGeAlD
Zuclopenthixol—DRD2—hindbrain—autistic disorder	0.00226	0.0223	CbGeAlD
Zuclopenthixol—DRD1—brainstem—autistic disorder	0.0022	0.0216	CbGeAlD
Zuclopenthixol—DRD1—forebrain—autistic disorder	0.00212	0.0209	CbGeAlD
Zuclopenthixol—DRD1—telencephalon—autistic disorder	0.00195	0.0192	CbGeAlD
Zuclopenthixol—HTR6—head—autistic disorder	0.00163	0.0161	CbGeAlD
Zuclopenthixol—DRD5—head—autistic disorder	0.00159	0.0156	CbGeAlD
Zuclopenthixol—HTR6—nervous system—autistic disorder	0.00155	0.0152	CbGeAlD
Zuclopenthixol—DRD5—nervous system—autistic disorder	0.00151	0.0148	CbGeAlD
Zuclopenthixol—HTR2A—hindbrain—autistic disorder	0.00149	0.0147	CbGeAlD
Zuclopenthixol—HTR6—central nervous system—autistic disorder	0.00149	0.0147	CbGeAlD
Zuclopenthixol—DRD5—central nervous system—autistic disorder	0.00145	0.0143	CbGeAlD
Zuclopenthixol—CYP2D6—hindbrain—autistic disorder	0.00136	0.0134	CbGeAlD
Zuclopenthixol—ADRA1A—brainstem—autistic disorder	0.00132	0.013	CbGeAlD
Zuclopenthixol—DRD2—brainstem—autistic disorder	0.0013	0.0128	CbGeAlD
Zuclopenthixol—ADRA1A—forebrain—autistic disorder	0.00128	0.0126	CbGeAlD
Zuclopenthixol—DRD2—eye—autistic disorder	0.00126	0.0124	CbGeAlD
Zuclopenthixol—DRD2—forebrain—autistic disorder	0.00125	0.0123	CbGeAlD
Zuclopenthixol—DRD1—head—autistic disorder	0.00121	0.0119	CbGeAlD
Zuclopenthixol—HTR6—brain—autistic disorder	0.00118	0.0116	CbGeAlD
Zuclopenthixol—ADRA1A—telencephalon—autistic disorder	0.00118	0.0116	CbGeAlD
Zuclopenthixol—DRD2—telencephalon—autistic disorder	0.00115	0.0113	CbGeAlD
Zuclopenthixol—DRD5—brain—autistic disorder	0.00115	0.0113	CbGeAlD
Zuclopenthixol—DRD1—nervous system—autistic disorder	0.00115	0.0113	CbGeAlD
Zuclopenthixol—DRD1—central nervous system—autistic disorder	0.00111	0.0109	CbGeAlD
Zuclopenthixol—HRH1—eye—autistic disorder	0.000998	0.00982	CbGeAlD
Zuclopenthixol—HRH1—forebrain—autistic disorder	0.000989	0.00973	CbGeAlD
Zuclopenthixol—ADRA2A—forebrain—autistic disorder	0.000972	0.00956	CbGeAlD
Zuclopenthixol—HRH1—telencephalon—autistic disorder	0.00091	0.00895	CbGeAlD
Zuclopenthixol—ADRA2A—telencephalon—autistic disorder	0.000893	0.00879	CbGeAlD
Zuclopenthixol—DRD1—brain—autistic disorder	0.00088	0.00866	CbGeAlD
Zuclopenthixol—HTR2A—brainstem—autistic disorder	0.000856	0.00842	CbGeAlD
Zuclopenthixol—HTR2A—eye—autistic disorder	0.000833	0.0082	CbGeAlD
Zuclopenthixol—HTR2A—forebrain—autistic disorder	0.000826	0.00813	CbGeAlD
Zuclopenthixol—Loxapine—HTR5A—autistic disorder	0.000803	0.0852	CrCbGaD
Zuclopenthixol—CYP2D6—brainstem—autistic disorder	0.00078	0.00767	CbGeAlD
Zuclopenthixol—HTR2A—telencephalon—autistic disorder	0.00076	0.00748	CbGeAlD
Zuclopenthixol—CYP2D6—forebrain—autistic disorder	0.000753	0.00741	CbGeAlD
Zuclopenthixol—ADRA1A—head—autistic disorder	0.000732	0.0072	CbGeAlD
Zuclopenthixol—DRD2—head—autistic disorder	0.000717	0.00706	CbGeAlD
Zuclopenthixol—HRH1—digestive system—autistic disorder	0.000694	0.00683	CbGeAlD
Zuclopenthixol—ADRA1A—nervous system—autistic disorder	0.000694	0.00683	CbGeAlD
Zuclopenthixol—CYP2D6—telencephalon—autistic disorder	0.000692	0.00681	CbGeAlD
Zuclopenthixol—DRD2—nervous system—autistic disorder	0.00068	0.00669	CbGeAlD
Zuclopenthixol—ADRA1A—central nervous system—autistic disorder	0.000668	0.00657	CbGeAlD
Zuclopenthixol—DRD2—central nervous system—autistic disorder	0.000655	0.00644	CbGeAlD
Zuclopenthixol—ADRA1A—cerebellum—autistic disorder	0.000653	0.00642	CbGeAlD
Zuclopenthixol—DRD2—cerebellum—autistic disorder	0.00064	0.0063	CbGeAlD
Zuclopenthixol—HTR2A—digestive system—autistic disorder	0.00058	0.00571	CbGeAlD
Zuclopenthixol—HRH1—head—autistic disorder	0.000566	0.00557	CbGeAlD
Zuclopenthixol—ADRA2A—head—autistic disorder	0.000556	0.00547	CbGeAlD
Zuclopenthixol—HRH1—nervous system—autistic disorder	0.000537	0.00528	CbGeAlD
Zuclopenthixol—ADRA1A—brain—autistic disorder	0.00053	0.00522	CbGeAlD
Zuclopenthixol—CYP2D6—digestive system—autistic disorder	0.000528	0.0052	CbGeAlD
Zuclopenthixol—ADRA2A—nervous system—autistic disorder	0.000527	0.00519	CbGeAlD
Zuclopenthixol—DRD2—brain—autistic disorder	0.00052	0.00511	CbGeAlD
Zuclopenthixol—HRH1—central nervous system—autistic disorder	0.000517	0.00509	CbGeAlD
Zuclopenthixol—ADRA2A—central nervous system—autistic disorder	0.000508	0.005	CbGeAlD
Zuclopenthixol—ADRA2A—cerebellum—autistic disorder	0.000496	0.00488	CbGeAlD
Zuclopenthixol—HTR2A—head—autistic disorder	0.000473	0.00466	CbGeAlD
Zuclopenthixol—HTR2A—nervous system—autistic disorder	0.000448	0.00441	CbGeAlD
Zuclopenthixol—HTR2A—central nervous system—autistic disorder	0.000432	0.00425	CbGeAlD
Zuclopenthixol—CYP2D6—head—autistic disorder	0.000431	0.00424	CbGeAlD
Zuclopenthixol—HTR2A—cerebellum—autistic disorder	0.000422	0.00415	CbGeAlD
Zuclopenthixol—HRH1—brain—autistic disorder	0.00041	0.00404	CbGeAlD
Zuclopenthixol—CYP2D6—nervous system—autistic disorder	0.000409	0.00402	CbGeAlD
Zuclopenthixol—ADRA2A—brain—autistic disorder	0.000403	0.00397	CbGeAlD
Zuclopenthixol—CYP2D6—central nervous system—autistic disorder	0.000393	0.00387	CbGeAlD
Zuclopenthixol—CYP2D6—cerebellum—autistic disorder	0.000384	0.00378	CbGeAlD
Zuclopenthixol—Flupentixol—DRD1—autistic disorder	0.000379	0.0402	CrCbGaD
Zuclopenthixol—HTR2A—brain—autistic disorder	0.000343	0.00337	CbGeAlD
Zuclopenthixol—Acetophenazine—DRD1—autistic disorder	0.000336	0.0356	CrCbGaD
Zuclopenthixol—CYP2D6—brain—autistic disorder	0.000312	0.00307	CbGeAlD
Zuclopenthixol—Propericiazine—DRD1—autistic disorder	0.000297	0.0315	CrCbGaD
Zuclopenthixol—Amoxapine—HTR3A—autistic disorder	0.000288	0.0306	CrCbGaD
Zuclopenthixol—Domperidone—DRD3—autistic disorder	0.00026	0.0275	CrCbGaD
Zuclopenthixol—Trifluoperazine—XDH—autistic disorder	0.000254	0.027	CrCbGaD
Zuclopenthixol—Amoxapine—GABRA1—autistic disorder	0.000231	0.0245	CrCbGaD
Zuclopenthixol—Loxapine—HTR3A—autistic disorder	0.000225	0.0239	CrCbGaD
Zuclopenthixol—Loxapine—HTR1D—autistic disorder	0.000223	0.0236	CrCbGaD
Zuclopenthixol—Quetiapine—HTR3A—autistic disorder	0.00022	0.0233	CrCbGaD
Zuclopenthixol—Quetiapine—HTR1D—autistic disorder	0.000218	0.0231	CrCbGaD
Zuclopenthixol—Flupentixol—HTR2A—autistic disorder	0.000206	0.0219	CrCbGaD
Zuclopenthixol—Clozapine—HTR3A—autistic disorder	0.000189	0.0201	CrCbGaD
Zuclopenthixol—Clozapine—HTR1D—autistic disorder	0.000187	0.0198	CrCbGaD
Zuclopenthixol—Thioproperazine—DRD1—autistic disorder	0.000187	0.0198	CrCbGaD
Zuclopenthixol—Thiothixene—DRD1—autistic disorder	0.000183	0.0195	CrCbGaD
Zuclopenthixol—Pipotiazine—DRD1—autistic disorder	0.000183	0.0195	CrCbGaD
Zuclopenthixol—Prochlorperazine—DRD3—autistic disorder	0.000179	0.0189	CrCbGaD
Zuclopenthixol—Amoxapine—HTR1B—autistic disorder	0.000169	0.0179	CrCbGaD
Zuclopenthixol—Amoxapine—DRD3—autistic disorder	0.000164	0.0174	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD3—autistic disorder	0.000162	0.0171	CrCbGaD
Zuclopenthixol—Amoxapine—DRD1—autistic disorder	0.000161	0.0171	CrCbGaD
Zuclopenthixol—Fluphenazine—DRD1—autistic disorder	0.000159	0.0168	CrCbGaD
Zuclopenthixol—Nefazodone—SLC6A4—autistic disorder	0.00015	0.0159	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD3—autistic disorder	0.000147	0.0156	CrCbGaD
Zuclopenthixol—Chlorprothixene—DRD1—autistic disorder	0.000144	0.0153	CrCbGaD
Zuclopenthixol—Trazodone—SLC6A4—autistic disorder	0.000139	0.0147	CrCbGaD
Zuclopenthixol—Thioridazine—DRD1—autistic disorder	0.000137	0.0145	CrCbGaD
Zuclopenthixol—Loxapine—HTR1B—autistic disorder	0.000132	0.014	CrCbGaD
Zuclopenthixol—Quetiapine—HTR1B—autistic disorder	0.000129	0.0137	CrCbGaD
Zuclopenthixol—Loxapine—DRD3—autistic disorder	0.000128	0.0136	CrCbGaD
Zuclopenthixol—Loxapine—DRD1—autistic disorder	0.000126	0.0134	CrCbGaD
Zuclopenthixol—Perphenazine—DRD1—autistic disorder	0.000125	0.0133	CrCbGaD
Zuclopenthixol—Quetiapine—DRD3—autistic disorder	0.000125	0.0133	CrCbGaD
Zuclopenthixol—Quetiapine—DRD1—autistic disorder	0.000123	0.013	CrCbGaD
Zuclopenthixol—Nefazodone—HTR2A—autistic disorder	0.000115	0.0122	CrCbGaD
Zuclopenthixol—Amoxapine—SLC6A4—autistic disorder	0.000114	0.0121	CrCbGaD
Zuclopenthixol—Clozapine—HTR1B—autistic disorder	0.000111	0.0118	CrCbGaD
Zuclopenthixol—Clozapine—DRD3—autistic disorder	0.000108	0.0114	CrCbGaD
Zuclopenthixol—Trazodone—HTR2A—autistic disorder	0.000107	0.0113	CrCbGaD
Zuclopenthixol—Clozapine—DRD1—autistic disorder	0.000106	0.0112	CrCbGaD
Zuclopenthixol—Thioproperazine—HTR2A—autistic disorder	0.000102	0.0108	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD3—autistic disorder	0.000101	0.0107	CrCbGaD
Zuclopenthixol—Pipotiazine—HTR2A—autistic disorder	0.0001	0.0106	CrCbGaD
Zuclopenthixol—Thiothixene—HTR2A—autistic disorder	0.0001	0.0106	CrCbGaD
Zuclopenthixol—Chlorpromazine—DRD1—autistic disorder	9.95e-05	0.0105	CrCbGaD
Zuclopenthixol—Loxapine—SLC6A4—autistic disorder	8.93e-05	0.00947	CrCbGaD
Zuclopenthixol—Amoxapine—HTR2A—autistic disorder	8.79e-05	0.00932	CrCbGaD
Zuclopenthixol—Fluphenazine—HTR2A—autistic disorder	8.64e-05	0.00916	CrCbGaD
Zuclopenthixol—Chlorprothixene—HTR2A—autistic disorder	7.87e-05	0.00834	CrCbGaD
Zuclopenthixol—Thioridazine—HTR2A—autistic disorder	7.44e-05	0.00789	CrCbGaD
Zuclopenthixol—Trifluoperazine—HTR2A—autistic disorder	6.91e-05	0.00732	CrCbGaD
Zuclopenthixol—Loxapine—HTR2A—autistic disorder	6.86e-05	0.00728	CrCbGaD
Zuclopenthixol—Perphenazine—HTR2A—autistic disorder	6.83e-05	0.00724	CrCbGaD
Zuclopenthixol—Quetiapine—HTR2A—autistic disorder	6.7e-05	0.0071	CrCbGaD
Zuclopenthixol—Clozapine—HTR2A—autistic disorder	5.76e-05	0.00611	CrCbGaD
Zuclopenthixol—Chlorpromazine—HTR2A—autistic disorder	5.42e-05	0.00575	CrCbGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PRKCB—autistic disorder	1.28e-05	7.63e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CALCA—autistic disorder	1.27e-05	7.56e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—POMC—autistic disorder	1.27e-05	7.53e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PRKCB—autistic disorder	1.26e-05	7.52e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—POMC—autistic disorder	1.26e-05	7.51e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TSC2—autistic disorder	1.26e-05	7.51e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PRKCB—autistic disorder	1.26e-05	7.51e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD1—autistic disorder	1.26e-05	7.5e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TSC1—autistic disorder	1.26e-05	7.5e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2—autistic disorder	1.26e-05	7.49e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PRKCB—autistic disorder	1.26e-05	7.49e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MEF2C—autistic disorder	1.26e-05	7.48e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SERPINE1—autistic disorder	1.26e-05	7.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—POMC—autistic disorder	1.24e-05	7.37e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—LEP—autistic disorder	1.24e-05	7.35e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—APOE—autistic disorder	1.24e-05	7.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PRKCB—autistic disorder	1.24e-05	7.35e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CYP19A1—autistic disorder	1.23e-05	7.31e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—TPH2—autistic disorder	1.23e-05	7.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PIK3CG—autistic disorder	1.23e-05	7.3e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NTRK2—autistic disorder	1.23e-05	7.3e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ITGB3—autistic disorder	1.23e-05	7.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—DRD3—autistic disorder	1.22e-05	7.26e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PIK3CG—autistic disorder	1.21e-05	7.2e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—DPYD—autistic disorder	1.21e-05	7.19e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PIK3CG—autistic disorder	1.21e-05	7.18e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PIK3CG—autistic disorder	1.2e-05	7.17e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL5—autistic disorder	1.19e-05	7.11e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PIK3CG—autistic disorder	1.18e-05	7.03e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CALCA—autistic disorder	1.18e-05	7.02e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—POMC—autistic disorder	1.17e-05	6.95e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PRKCB—autistic disorder	1.17e-05	6.93e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRL—autistic disorder	1.16e-05	6.93e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—POMC—autistic disorder	1.15e-05	6.85e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—POMC—autistic disorder	1.15e-05	6.84e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PRKCB—autistic disorder	1.15e-05	6.83e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—POMC—autistic disorder	1.15e-05	6.82e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRL—autistic disorder	1.15e-05	6.82e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HTR2A—autistic disorder	1.14e-05	6.81e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRL—autistic disorder	1.14e-05	6.81e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—autistic disorder	1.14e-05	6.8e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—COMT—autistic disorder	1.14e-05	6.8e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GSTP1—autistic disorder	1.14e-05	6.77e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MAOA—autistic disorder	1.13e-05	6.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—autistic disorder	1.13e-05	6.7e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CACNA1C—autistic disorder	1.12e-05	6.69e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRL—autistic disorder	1.12e-05	6.68e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PIK3CG—autistic disorder	1.12e-05	6.64e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—APC—autistic disorder	1.12e-05	6.64e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CAT—autistic disorder	1.11e-05	6.58e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADRB2—autistic disorder	1.1e-05	6.58e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGF—autistic disorder	1.1e-05	6.56e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PIK3CG—autistic disorder	1.1e-05	6.54e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADRB2—autistic disorder	1.09e-05	6.47e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TSC2—autistic disorder	1.09e-05	6.47e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADRB2—autistic disorder	1.08e-05	6.46e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADRB2—autistic disorder	1.06e-05	6.34e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LEP—autistic disorder	1.06e-05	6.33e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APOE—autistic disorder	1.06e-05	6.33e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—autistic disorder	1.06e-05	6.32e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—HRAS—autistic disorder	1.06e-05	6.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—autistic disorder	1.05e-05	6.22e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PLA2G4A—autistic disorder	1.04e-05	6.22e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GSTM1—autistic disorder	1.04e-05	6.22e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRL—autistic disorder	1.04e-05	6.2e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AVP—autistic disorder	1.04e-05	6.18e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF2—autistic disorder	1.03e-05	6.15e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—MAPK1—autistic disorder	1.03e-05	6.13e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—DHFR—autistic disorder	1.02e-05	6.08e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AVP—autistic disorder	1.02e-05	6.08e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1—autistic disorder	1.02e-05	6.08e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AVP—autistic disorder	1.02e-05	6.07e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF2—autistic disorder	1.02e-05	6.05e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—autistic disorder	1.02e-05	6.05e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—MAPK1—autistic disorder	1.02e-05	6.05e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF2—autistic disorder	1.01e-05	6.04e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—autistic disorder	1.01e-05	6.02e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PRKCB—autistic disorder	1e-05	5.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GPX1—autistic disorder	1e-05	5.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AVP—autistic disorder	1e-05	5.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF2—autistic disorder	9.96e-06	5.93e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRB2—autistic disorder	9.89e-06	5.89e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PLA2G4A—autistic disorder	9.76e-06	5.81e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SERPINE1—autistic disorder	9.7e-06	5.77e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PLA2G4A—autistic disorder	9.6e-06	5.72e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—APC—autistic disorder	9.6e-06	5.71e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PIK3CG—autistic disorder	9.6e-06	5.71e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PLA2G4A—autistic disorder	9.58e-06	5.7e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—PTEN—autistic disorder	9.57e-06	5.69e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—autistic disorder	9.51e-06	5.66e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MEF2C—autistic disorder	9.49e-06	5.65e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGF—autistic disorder	9.49e-06	5.65e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PLA2G4A—autistic disorder	9.4e-06	5.6e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—autistic disorder	9.35e-06	5.57e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MEF2C—autistic disorder	9.34e-06	5.56e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—autistic disorder	9.33e-06	5.55e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MEF2C—autistic disorder	9.32e-06	5.55e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AVP—autistic disorder	9.29e-06	5.53e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ITGB3—autistic disorder	9.25e-06	5.51e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF2—autistic disorder	9.25e-06	5.51e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MTHFR—autistic disorder	9.23e-06	5.5e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—autistic disorder	9.16e-06	5.45e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MEF2C—autistic disorder	9.15e-06	5.44e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—autistic disorder	9.14e-06	5.44e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ITGB3—autistic disorder	9.1e-06	5.42e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ITGB3—autistic disorder	9.08e-06	5.41e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ITGB3—autistic disorder	8.91e-06	5.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1—autistic disorder	8.79e-06	5.23e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—MAPK1—autistic disorder	8.75e-06	5.21e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	8.74e-06	5.2e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HTR2A—autistic disorder	8.64e-06	5.14e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—autistic disorder	8.63e-06	5.14e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—APOE—autistic disorder	8.6e-06	5.12e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	8.51e-06	5.06e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	8.5e-06	5.06e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—autistic disorder	8.49e-06	5.06e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HTR2A—autistic disorder	8.48e-06	5.05e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—autistic disorder	8.48e-06	5.04e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SERPINE1—autistic disorder	8.35e-06	4.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HTR2A—autistic disorder	8.32e-06	4.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—autistic disorder	8.32e-06	4.95e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	8.28e-06	4.93e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—HRAS—autistic disorder	8.27e-06	4.92e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TSC2—autistic disorder	8.21e-06	4.88e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—HRAS—autistic disorder	8.16e-06	4.85e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TSC2—autistic disorder	8.07e-06	4.81e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TSC2—autistic disorder	8.06e-06	4.79e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOE—autistic disorder	8.03e-06	4.78e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LEP—autistic disorder	8.03e-06	4.78e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CYP19A1—autistic disorder	8.01e-06	4.77e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TSC2—autistic disorder	7.91e-06	4.7e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—autistic disorder	7.9e-06	4.7e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOE—autistic disorder	7.9e-06	4.7e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOE—autistic disorder	7.88e-06	4.69e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—autistic disorder	7.88e-06	4.69e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—autistic disorder	7.85e-06	4.67e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—autistic disorder	7.81e-06	4.65e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MAPK1—autistic disorder	7.78e-06	4.63e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PIK3CG—autistic disorder	7.76e-06	4.62e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—autistic disorder	7.74e-06	4.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOE—autistic disorder	7.74e-06	4.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	7.73e-06	4.6e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—autistic disorder	7.73e-06	4.6e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRKCB—autistic disorder	7.57e-06	4.51e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRKCB—autistic disorder	7.45e-06	4.43e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—COMT—autistic disorder	7.44e-06	4.43e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRKCB—autistic disorder	7.44e-06	4.42e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTP1—autistic disorder	7.41e-06	4.41e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MAOA—autistic disorder	7.39e-06	4.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—autistic disorder	7.39e-06	4.4e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PTEN—autistic disorder	7.38e-06	4.39e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TSC2—autistic disorder	7.35e-06	4.37e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKCB—autistic disorder	7.3e-06	4.34e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APC—autistic disorder	7.25e-06	4.31e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PIK3CG—autistic disorder	7.25e-06	4.31e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAT—autistic disorder	7.21e-06	4.29e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—autistic disorder	7.19e-06	4.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOE—autistic disorder	7.19e-06	4.28e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGF—autistic disorder	7.16e-06	4.26e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PIK3CG—autistic disorder	7.13e-06	4.24e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APC—autistic disorder	7.13e-06	4.24e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APC—autistic disorder	7.12e-06	4.23e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PIK3CG—autistic disorder	7.12e-06	4.23e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGF—autistic disorder	7.05e-06	4.19e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGF—autistic disorder	7.03e-06	4.19e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—HRAS—autistic disorder	7.02e-06	4.18e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PIK3CG—autistic disorder	6.98e-06	4.16e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APC—autistic disorder	6.98e-06	4.16e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGF—autistic disorder	6.9e-06	4.11e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—autistic disorder	6.9e-06	4.11e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTM1—autistic disorder	6.81e-06	4.05e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	6.81e-06	4.05e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—autistic disorder	6.79e-06	4.04e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	6.78e-06	4.03e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—autistic disorder	6.77e-06	4.03e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—autistic disorder	6.75e-06	4.02e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—autistic disorder	6.72e-06	4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—autistic disorder	6.65e-06	3.96e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—autistic disorder	6.64e-06	3.95e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—MAPK1—autistic disorder	6.6e-06	3.93e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—autistic disorder	6.53e-06	3.89e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX1—autistic disorder	6.52e-06	3.88e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—autistic disorder	6.52e-06	3.88e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—MAPK1—autistic disorder	6.5e-06	3.87e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APC—autistic disorder	6.49e-06	3.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	6.49e-06	3.86e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—MAPK1—autistic disorder	6.48e-06	3.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGF—autistic disorder	6.41e-06	3.82e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—autistic disorder	6.39e-06	3.8e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—MAPK1—autistic disorder	6.36e-06	3.79e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTEN—autistic disorder	6.36e-06	3.78e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—autistic disorder	6.3e-06	3.75e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—HRAS—autistic disorder	6.24e-06	3.72e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—autistic disorder	6.2e-06	3.69e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—autistic disorder	6.19e-06	3.68e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—autistic disorder	6.18e-06	3.68e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—autistic disorder	6.07e-06	3.61e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—autistic disorder	6.02e-06	3.58e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK1—autistic disorder	6e-06	3.57e-05	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—autistic disorder	5.98e-06	3.56e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—autistic disorder	5.94e-06	3.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	5.91e-06	3.52e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—autistic disorder	5.89e-06	3.51e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	5.64e-06	3.36e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOE—autistic disorder	5.6e-06	3.33e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—HRAS—autistic disorder	5.3e-06	3.16e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—HRAS—autistic disorder	5.22e-06	3.1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—HRAS—autistic disorder	5.21e-06	3.1e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK1—autistic disorder	5.17e-06	3.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTEN—autistic disorder	5.14e-06	3.06e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—HRAS—autistic disorder	5.11e-06	3.04e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—autistic disorder	5.1e-06	3.04e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—autistic disorder	5.07e-06	3.02e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PIK3CG—autistic disorder	5.06e-06	3.01e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—autistic disorder	5.02e-06	2.99e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—autistic disorder	5.01e-06	2.98e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—autistic disorder	4.99e-06	2.97e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—autistic disorder	4.98e-06	2.97e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—autistic disorder	4.91e-06	2.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—autistic disorder	4.89e-06	2.91e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—HRAS—autistic disorder	4.82e-06	2.87e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—autistic disorder	4.81e-06	2.86e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTEN—autistic disorder	4.8e-06	2.86e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	4.75e-06	2.82e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTEN—autistic disorder	4.72e-06	2.81e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTEN—autistic disorder	4.71e-06	2.8e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTEN—autistic disorder	4.62e-06	2.75e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—autistic disorder	4.61e-06	2.74e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—autistic disorder	4.57e-06	2.72e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—autistic disorder	4.54e-06	2.7e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTEN—autistic disorder	4.3e-06	2.56e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—HRAS—autistic disorder	4.15e-06	2.47e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—autistic disorder	3.97e-06	2.36e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK1—autistic disorder	3.9e-06	2.32e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK1—autistic disorder	3.84e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—autistic disorder	3.84e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK1—autistic disorder	3.83e-06	2.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK1—autistic disorder	3.76e-06	2.24e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	3.49e-06	2.08e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTEN—autistic disorder	3.35e-06	1.99e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—HRAS—autistic disorder	3.13e-06	1.86e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—HRAS—autistic disorder	3.08e-06	1.83e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—HRAS—autistic disorder	3.08e-06	1.83e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—HRAS—autistic disorder	3.02e-06	1.8e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—autistic disorder	3e-06	1.78e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—autistic disorder	2.95e-06	1.76e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—autistic disorder	2.94e-06	1.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—autistic disorder	2.89e-06	1.72e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—HRAS—autistic disorder	2.8e-06	1.67e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—autistic disorder	2.68e-06	1.6e-05	CbGpPWpGaD
